Skip to content

    COPD Health Center

    Font Size
    A
    A
    A

    FDA OKs Asthma Drug for COPD

    Symbicort Approved to Treat Chronic Obstructive Pulmonary Disease
    By
    WebMD Health News
    Reviewed by Louise Chang, MD

    March 2, 2009 -- The FDA has approved the use of Symbicort pMDI (pressurized metered-dose inhaler), which is used to treat asthma, to treat chronic obstructive pulmonary disease (COPD).

    According to AstraZeneca, which makes Symbicort, the FDA approved Symbicort for COPD based on two clinical trials that included more than 3,600 COPD patients aged 40 and older.

    Symbicort is delivered by an inhaler. Its active ingredients are formoterol (a long-acting beta agonist) and budesonide (a corticosteroid).

    In the clinical trials, COPD patients taking Symbicort had a greater improvement in their lung function, compared to patients using a placebo, formoterol, or budesonide.

    It typically took five minutes for lung function to start to improve with Symbicort treatment, and Symbicort was generally well tolerated.

    In one of the trials, which lasted for a year, potential lung infections other than pneumonia were more common among patients using Symbicort than among those using the placebo or formoterol. The most common side effects were colds, oral thrush, bronchitis, sinusitis, and viral infections of the upper respiratory tract.

    Today on WebMD

    man talking to his doctor
    Check your COPD risk.
    woman using inhaler
    What is the top cause of this condition?
     
    chest x-ray
    7 early warning signs.
    Senior couple stretching
    10 exercises for people With COPD.
     
    Bronchitis Overview
    Article
    Senior woman blowing dandelion
    ARTICLE
     
    Living With Copd
    VIDEO
    human lung graphic
    Article
     
    Energy Boosting Foods
    Slideshow
    red heart and ekg
    Article
     
    Living With Copd
    Article
    Senior couple stretching
    Slideshow
     

    WebMD Special Sections